#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fontan procedure Small for dates baby Ehlers-Danlos syndrome Mucous membrane pemphigoid Hodgkin's disease recurrent Arrhythmia Guillain-Barre syndrome Usher's syndrome Congenital generalised lipodystrophy Inborn error of metabolism Acute graft versus host disease in liver Hodgkin's disease refractory Hereditary hypophosphataemic rickets Liver abscess Crohn's disease More trials…

    Learn about Rare Diseases

    Rett syndrome – Life with Disease Haemophilia – Diagnostics Friedreich’s ataxia – Trials in Disease Glycogen storage disease type II Primary immunodeficiency syndrome – Life with Disease Marginal zone lymphoma – Diagnostics Crigler-Najjar syndrome Propionic acidaemia Cytokine release syndrome – Life with Disease Wolfram syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mycophenolic Acid Sertraline Atorvastatin Calcium GSK4524101A Ketamine Ilofotase Alfa Efruxifermin Garetosmab Emicizumab Amcenestrant Gelatin Temozolomide Salbutamol Sulfate Ph. Eur. Sodium Gluconate Belinostat Eftilagimod Alfa Eribulin Mesylate CLESROVIMAB Niraparib Lovo-A More therapies…

    Learn about Your Condition

    Suicidal ideation Round cell liposarcoma Pulmonary venous thrombosis Graft infection Cervix carcinoma stage IV Poor quality sleep Nervous system disorder Mitral valve prolapse Eye pain Fatty acid oxidation disorder Laryngeal cancer stage III Inclusion body myositis Adenocarcinoma of colon Anxiety Squamous cell carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Age-related macular degeneration

  • Study on the Effectiveness and Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a 36-Week Refill System

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    Austria Belgium France Germany Italy Spain

  • Study on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Faricimab
    Austria

  • Study on the Use of 68Ga-NODAGA-RGD for Monitoring Treatment in Patients with Age-Related Macular Degeneration

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • 5-[4-[(2S,5S,11S,14R)-14-Benzyl-11-(Carboxymethyl)-5-[3-(Diaminomethylideneamino)Propyl]-3,6,9,12,15-Pentaoxo-1,4,7,10,13-Pentazacyclopentadec-2-Yl]Butylamino]-2-[4,7-Bis(Carboxymethyl)-1,4,7-Triazonan-1-Yl]-5-Oxopentanoic Acid Radioallebled With Gallium-68
    France

  • Study on the Effectiveness of Bevacizumab and Ranibizumab in Treating Age-Related Macular Degeneration in Patients with Genetic Variations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    • Bevacizumab
    Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!